
CHONDROPROTEC® is a polysulfated glycosaminoglycan dressing which supports or enhances the connective tissue matrix. Rehydrates dry wounds and maintains a moist healing environment.
• Creates an optimal moist healing environment
• Promotes natural autolysis by rehydrating and softening necrotic tissue and eschar thereby encouraging autolytic debridement
• Conforms to any wound site
• Easy to apply and redress
CHONDROPROTEC® is indicated for use in the management of pressure ulcers (stages 1-4), venous stasis ulcers, first- and second-degree burns, secreting and bleeding dermal lesions, trauma injuries, partial- and full-thickness wounds, surgical incisions and donor sites.
CHONDROPROTEC® is a sterile solution of polysulfated glycosaminoglycan and should be handled accordingly. Wounds that are contaminated and/or infected should be debrided prior to using the CHONDROPROTEC® product.
Store at temperatures between 15°C-30°C. Protect from freezing.
Polysulfated glycosaminoglycan
Antimicrobial format available | |
Color change w/ moisture activation | |
Compatible w/ topicals | ● |
Cuttable | |
Gels on contact w/ exudate | |
Intact when saturated | |
Moisture vapor permeable | |
Moldable | |
One-piece removal | |
Paste | |
Powder | |
Rope | |
Sustained release formula | |
Unit dose | |
Usable on infected wounds |
Educational Material Available | ● |
Free Samples/Trials Available | ● |
Published Clinical Article Available | ● |
Acute Wounds
Burns
Cavity Wounds
Chronic Wounds
Deep Wounds
Dehisced Wounds
Diabetic Foot
Dry Skin Conditions
Granulating/Epithelializing Wounds
Non/Minimally Exudating Wounds
Pressure Ulcers
Superficial Wounds
Surgical Wounds
Traumatic Wounds
Venous Ulcers
Irrigate wound with normal saline solution. Either pour contents of vial or dispense from syringe to withdraw CHONDROPROTEC® and cover wound site. Cover with a non-adherent dressing. Note: subsequent applications of CHONDROPROTEC® can be through the dressing as to not disturb the wound bed.
Reapply CHONDROPROTEC® daily and redress wound site every five to seven days or as needed.
Hymed develops and manufactures collagen, hyaluronic acid and glycosaminoglycan based specialty wound care products, with a focus on combining innovative ingredients synergistically to support the connective tissue matrix.